Breast Cancer Research and Treatment Journal Citation Rate 2026

ISSN 0167-6806 eISSN 1573-7217 Springer Science+Business Media NL

Q2 Quartile Established Impact

About Breast Cancer Research and Treatment
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Breast Cancer Research and Treatment (BCRT) is a peer-reviewed academic journal covering BRCA gene mutations in cancer and Breast Cancer Treatment Studies, published by Springer Science+Business Media in NL, catalogued under ISSN 0167-6806 (e-ISSN 1573-7217). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 2.82 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$3790 USD). OpenAlex records 12,466 works and 511,195 citations, with an h-index of 221.

Breast Cancer Research and Treatment Citation Rate 2026 — In Context

Breast Cancer Research and Treatment has a 2025 2-Year Citation Rate (OpenAlex) of 2.82, placing it in the Q2 quartile within the BRCA gene mutations in cancer research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Breast Cancer Research and Treatment operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Breast Cancer Research and Treatment should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Breast Cancer Research and Treatment against similar journals in the field, use our journal comparison tool.

Submission Tips for Breast Cancer Research and Treatment
  • Budget $3790 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers BRCA gene mutations in cancer, Breast Cancer Treatment Studies, Breast Lesions and Carcinomas. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Breast Cancer Research … Compares
Citation Rate vs Field Avg
+20%
Field avg: 2.36
APC vs Field Avg
+19%
Field avg: $3184

Compared against 25 journals in the same research areas.

ISSN (Print) 0167-6806
ISSN (Online) 1573-7217
Publisher Springer Science+Business Media
Country Netherlands
APC / Cost $3790 USD
In-depth profile & metrics

Breast Cancer Research and Treatment is published by Springer Science+Business Media and based in Netherlands. It runs on a subscription or hybrid model with an article-processing charge of USD 3790.

In our subject taxonomy, Breast Cancer Research and Treatment is classified under BRCA gene mutations in cancer, Breast Cancer Treatment Studies, Breast Lesions and Carcinomas and Estrogen and related hormone effects.

Breast Cancer Research and Treatment is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 2.818.

Research Areas
Links
Frequently Asked Questions about Breast Cancer Research and Treatment

Breast Cancer Research and Treatment does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 2.818 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Breast Cancer Research and Treatment is not an open access journal.

The Article Processing Charge (APC) for Breast Cancer Research and Treatment is $3790 USD.

Breast Cancer Research and Treatment is published by Springer Science+Business Media.

Breast Cancer Research and Treatment shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Breast Cancer Research and Treatment is 0167-6806. Its electronic ISSN (eISSN) is 1573-7217.

Breast Cancer Research and Treatment sits in the Q2 quartile based on its latest impact factor of 2.82, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
2.818
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 2.818 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Compare Journals

Compare Breast Cancer Research and Tr… against similar publications in its field:

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S142211178

Get weekly updates for BRCA gene mutations in cancer journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google